Genentech to invest $750M in device fill-finish facility in Hillsboro, Oregon

Genentech announced plans to invest approximately $750 million in a new device fill-finish manufacturing facility at its Hillsboro, Oregon campus. The expansion will double the facility size, create 250 high-wage manufacturing jobs and 200 construction jobs, with commercial operations expected to begin in 2031.

“The investment will bring new end-to-end device filling capabilities to the site and expand Genentech's capacity to support its future pipeline of innovative medicines.”gene.com

• 2 sources
• gene.comGenentech: Press Releases | Genentech Announces Manufacturing Expansion in Hillsboro, OregonAug 20, 2026
• gene.comGenentech: Press Releases | Monday, Sep 28, 2026Sep 28, 2026

Summarized from public sources; check the original articles before acting on it.